Servicios Personalizados
Articulo
Indicadores
Links relacionados
Citado por Google
Similares en Google
Compartir
Southern African Journal of HIV Medicine
versión On-line ISSN 2078-6751
versión impresa ISSN 1608-9693
Resumen
KAMURAI, Bridget et al. Effect of dolutegravir on ferritin, iron, and C-reactive protein among people living with HIV and co-infections. South. Afr. j. HIV med. (Online) [online]. 2024, vol.25, n.1, pp.1-6. ISSN 2078-6751. http://dx.doi.org/10.4102/sajhivmed.v25i1.1543.
BACKGROUND: Dolutegravir-based antiretroviral therapy (ART) is currently recommended as the preferred first-line ART in many resource-limited settings. However, little is known about the clinical experience of dolutegravir within a context of prevalent co-infections OBJECTIVES: To assess virological outcomes, and iron, ferritin and C-reactive protein (CRP) levels among people living with HIV (PLWH) and co-infections after initiating or re-initiating dolutegravir-based ART METHOD: This prospective study was conducted between August 2022 and August 2023. Study participants were recruited from an HIV opportunistic infection clinic. Screening for co-infections (syphilis, hepatitis B virus, cytomegalovirus and herpes simplex virus) was performed at baseline, prior to ART initiation. Plasma HIV viral load (VL), CRP, ferritin and iron levels were measured at baseline and at the 6-month follow-up period RESULTS: A total of 100 participants (51 women and 49 men) were enrolled in this study. The median age of the participants was 39 years. The prevalence of co-infections was 30%. Prior to ART initiation, participants with co-infections had higher VL, CRP and ferritin, and lower iron levels, compared to those without co-infections (P < 0.001). Following 6 months of ART, CRP and ferritin levels decreased while iron levels increased, regardless of co-infection status. However, CRP and ferritin remained significantly higher in those with co-infections despite similar and high rates of virologic suppression in both groups CONCLUSION: The presence of co-infections in PLWH is associated with higher VL and with chronic inflammation. Ferritin and CRP decreased on dolutegravir-based ART but remained higher in people with co-infections despite similar rates of virologic suppression
Palabras clave : HIV; co-infections; ferritin; iron; virological outcomes; dolutegravir.
![](/img/en/iconPDFDocument.gif)